Significance of cytologic criteria in distinguishing small cell from non-small cell carcinoma of the lung

被引:20
作者
Arora, VK [1 ]
Singh, N
Chaturvedi, S
Bhatia, A
机构
[1] Univ Coll Med Sci, Cytol Sect, Dept Pathol, Delhi 110095, India
[2] Guru Teg Bahadur Hosp, Delhi 110095, India
关键词
D O I
10.1159/000326507
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
OBJECTIVE: To study the significance of cytologic futures in distinguishing small cell carcinoma (SCC) from non-small cell carcinoma (NSCC). STUDY DESIGN: Prospective study of 76 patients with lung carcinoma. Percutaneous fine needle aspiration and bronchial washings stained with Papanicolaou and May-Grunwald-Giemsa stain were used for categorization of tumors according to the World Health Organization classification. Each tumor was also scored for the presence or absence of standard cytologic criteria used in the diagnosis of SCC. Data were analyzed for sensitivity, specificity and significance using the chi(2) and Fisher exact tests. Undifferentiated and unclassified tumors were examined immunocytochemically for the presence of neuron-specific enolase, epithelial membrane antigen and leukocyte common antigen. Cytologic diagnoses were compared with histopathologic diagnoses. RESULTS: Seventy-six lesions classified on cytomorphology consisted of SCC (15), NSCC (50), non-Hodgkin's lymphoma (1), carcinoid (1) and undifferentiated or poorly differentiated carcinomas (9), 2 of which showed nuclear molding and salt-and-pepper chromatin. Immunocytochemistry and biopsy confirmed the diagnosis of SCC in those two patients, CONCLUSION: Nuclear molding, cell size and scant, basophilic cytoplasm were highly sensitive and specific by univariate analysis for distinguishing SCC from NSCC. Other features, such as salt-and-pepper chromatin, crush artifact and apoptotic bodies, also had significantly high specificity; however, their low sensitivity precluded their usefulness in separating SCC from NSCC. Thus, morphologic evaluation plays a major role, while immunocytochemistry can make a limited contribution in differentiating SCC from NSCC.
引用
收藏
页码:216 / 220
页数:5
相关论文
共 16 条
[1]  
BEDROSSIAN CWM, 1976, ACTA CYTOL, V20, P446
[2]  
Colby T, 1995, ATLAS TUMOR PATHOL, P235
[3]  
COLBY TV, 1995, ATLAS TUMOR PATHOL, P135
[4]  
Delgado PI, 2000, CANCER CYTOPATHOL, V90, P279, DOI 10.1002/1097-0142(20001025)90:5<279::AID-CNCR3>3.0.CO
[5]  
2-D
[6]  
HANSEN HH, 1997, TXB MED ONCOLOGY, P139
[7]  
JOHNSTON WW, 1984, ACTA CYTOL, V28, P218
[8]  
MICHEL RP, 1983, CANCER, V51, P663
[9]  
Noguchi M, 1992, Jpn J Clin Oncol, V22, P6
[10]  
PILLOTI S, 1984, ACTA CYTOL, V28, P225